Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe

Inge Geelen; N Thielen; J Janssen; M Hoogendoorn; TJA Roosma; Peter Valk; O Visser; Jan Cornelissen; PE Westerweel

doi:10.1111/ejh.13023

Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe

Inge Geelen, N Thielen, J Janssen, M Hoogendoorn, TJA Roosma, Peter Valk, O Visser, Jan Cornelissen, PE Westerweel

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	367-371
Number of pages	5
Journal	European Journal of Haematology
Volume	100
Issue number	4
DOIs	https://doi.org/10.1111/ejh.13023
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1111/ejh.13023

http://hdl.handle.net/1765/104631

Cite this

@article{bd22ad369aa1480aa465efa9bc4e266a,

title = "Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe",

author = "Inge Geelen and N Thielen and J Janssen and M Hoogendoorn and TJA Roosma and Peter Valk and O Visser and Jan Cornelissen and PE Westerweel",

year = "2018",

doi = "10.1111/ejh.13023",

language = "Undefined/Unknown",

volume = "100",

pages = "367--371",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley & Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Omitting cytogenetic assessment from routine treatment response monitoring in chronic myeloid leukemia is safe

AU - Geelen, Inge

AU - Thielen, N

AU - Janssen, J

AU - Hoogendoorn, M

AU - Roosma, TJA

AU - Valk, Peter

AU - Visser, O

AU - Cornelissen, Jan

AU - Westerweel, PE

PY - 2018

Y1 - 2018

U2 - 10.1111/ejh.13023

DO - 10.1111/ejh.13023

M3 - Article

C2 - 29288559

SN - 0902-4441

VL - 100

SP - 367

EP - 371

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 4

ER -